# Clozapine/Paliperidone Versus Clozapine/Placebo in Resistant Schizophrenia

> **NCT01279213** · PHASE4 · COMPLETED · sponsor: **Universidad Nacional de Rosario** · enrollment: 70 (actual)

## Conditions studied

- Schizophrenia
- Schizophrenic Disorders
- Psychotic Disorder

## Interventions

- **DRUG:** paliperidone clozapine

## Key facts

- **NCT ID:** NCT01279213
- **Lead sponsor:** Universidad Nacional de Rosario
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2009-10
- **Final completion:** 2009-12
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2011-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01279213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01279213, "Clozapine/Paliperidone Versus Clozapine/Placebo in Resistant Schizophrenia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01279213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*